NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 315 filers reported holding NEOGENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,551,313 | -44.5% | 126,123 | -27.4% | 0.00% | 0.0% |
| Q2 2023 | $2,792,645 | +295.2% | 173,780 | +328.1% | 0.00% | – |
| Q1 2023 | $706,707 | +3.8% | 40,592 | -44.9% | 0.00% | – |
| Q4 2022 | $681,006 | +432.0% | 73,702 | +397.0% | 0.00% | – |
| Q3 2022 | $128,000 | -95.6% | 14,829 | -93.8% | 0.00% | – |
| Q1 2022 | $2,896,000 | -19.6% | 238,392 | +125.7% | 0.00% | -100.0% |
| Q4 2021 | $3,603,000 | -37.5% | 105,610 | -11.7% | 0.00% | -50.0% |
| Q3 2021 | $5,766,000 | +128.5% | 119,542 | +114.0% | 0.00% | – |
| Q2 2021 | $2,523,000 | -62.3% | 55,856 | -59.7% | 0.00% | -100.0% |
| Q1 2021 | $6,684,000 | +124.9% | 138,590 | +151.1% | 0.00% | +200.0% |
| Q4 2020 | $2,972,000 | +105.0% | 55,193 | +40.4% | 0.00% | – |
| Q3 2020 | $1,450,000 | +9.8% | 39,298 | -7.8% | 0.00% | -100.0% |
| Q2 2020 | $1,320,000 | -69.9% | 42,600 | -87.8% | 0.00% | -88.9% |
| Q4 2018 | $4,391,000 | – | 348,184 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |